Overexpression of estrogen receptor beta and its prognostic significance among malignant pleural mesothelioma patients

被引:0
|
作者
Helali, Mariam [1 ,3 ]
Abdelmotal, Ahmed [1 ]
Gobran, Nagy [1 ]
El Ghazaly, Hesham [1 ]
El Mahdy, Manal [2 ]
Karim, Khaled [1 ]
机构
[1] Ain Shams Univ, Fac Med, Clin Oncol Dept, Cairo, Egypt
[2] Ain Shams Univ, Fac Med, Pathol Dept, Cairo, Egypt
[3] 38 Abbassia,Next Al Nour Mosque, Cairo, Egypt
来源
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS | 2024年 / 73卷 / 01期
关键词
mesothelioma; ER beta; prognostic; biomarkers; HEALTH;
D O I
10.4103/ecdt.ecdt_25_23
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background The overexpression of estrogen receptor beta (ER beta) and its correlation with prognosis of malignant mesothelioma remains controversial and unexplored. This study aimed at studying ER beta expression in tumour tissue in patients with pleural mesothelioma and its association with clinical and pathological factors and survival analysis. Material and methods A prospective cohort study was conducted on patients who were diagnosed with malignant pleural mesothelioma (MPM) in Ain Shams university hospitals, the primary end point was to correlate ER beta overexpression that was analysed by immunohistochemistry (IHC) on paraffin tissue blocks with 1-year overall survival (OS) among MPM patients, the secondary endpoint was to correlate ER beta overexpression with 1-year progression free survival (PFS) and response to platinum-based chemotherapy among MPM patients. Results A total 42 MPM patients were included, High ER beta expression (modified Allred score 7-9) was reported in 9.5% of the patients (4 cases), moderate expression (modified Allred score 4-6) was reported in 28.6% of the patients(12 cases), weak and negative expression ( modified Allred score 0-3) was reported in 61% of the patients(26 cases), percent of ER beta positive cases was 69% of the total patients, there was no statistical difference as regard age (p value:0.8), sex(p value:0.4), stage (p value: 0.71), ECOG (p value :0.84) , histological subtype(p value:0.17) and response to platinum based treatment (p value:0.5) across the 3 groups of patients (high, moderate , weak and negative ER beta on tumour tissues) there was no statistically significant difference in OS and PFS for ER beta overexpression. Conclusion The overexpression of ER beta was not associated with improved OS or PFS in mesothelioma patients, despite high rate of ER beta positive cases in our analysis, larger sample size would be recommended for more solid conclusions
引用
收藏
页码:85 / 90
页数:6
相关论文
共 50 条
  • [1] Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma
    Rafael Rodriguez-Cid, Jeronimo
    Garcia-Acevedo, Orlando
    Benjamin-Contreras, Javier
    Bonilla-Molina, Diana
    Rafael Flores-Marinelarena, Rodrigo
    Martinez-Barrera, Luis
    Arturo Alatorre-Alexander, Jorge
    Paola Sanchez-Rios, Carla
    del Rosario Flores-Soto, Maria
    Javier Santillan-Doherty, Patricio
    Sagrario Pena-Mirabal, Erika
    JOURNAL OF THORACIC DISEASE, 2019, 11 (04) : 1456 - 1464
  • [2] Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma
    Emri, S
    Akbulut, H
    Zorlu, F
    Dinçol, D
    Akay, H
    Güngen, Y
    Içli, F
    LUNG CANCER, 2001, 33 (2-3) : 109 - 114
  • [3] Prognostic Factors in Malignant Pleural Mesothelioma
    Kirschner, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S12 - S12
  • [4] Prognostic significance of presence and reduplication of basal lamina in malignant pleural mesothelioma
    Di Muzio, M
    Spoletini, L
    Strizzi, L
    Vianale, G
    Fontana, V
    Orengo, MA
    Tassi, G
    Casalini, A
    Mutti, L
    Procopio, A
    HUMAN PATHOLOGY, 2000, 31 (11) : 1341 - 1345
  • [5] Prognostic factors for malignant pleural mesothelioma
    Fraser J. H. Brims
    Nick A. Maskell
    Current Respiratory Care Reports, 2013, 2 (2): : 100 - 108
  • [6] Prognostic factors for malignant pleural mesothelioma
    Brims, Fraser J. H.
    Maskell, Nick A.
    CURRENT PULMONOLOGY REPORTS, 2013, 2 (02) : 100 - 108
  • [7] Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma
    Liu, Hui
    Wu, Licun
    Ji, Kai
    Wang, Wei
    TUMOR BIOLOGY, 2015, 36 (10) : 7375 - 7384
  • [8] Immunohistochemistry as Prognostic Markers for Malignant Pleural Mesothelioma
    Otsuki, Taiichiro
    Maehashi, Nobuko
    Kataoka, Yuki
    Terada, Takayuki
    Kuribayashi, Kozo
    Hirabayashi, Masataka
    Ieki, Ryuji
    Nakano, Takashi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S505 - S505
  • [9] Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma
    Yamada, Shusai
    Tabata, Chiharu
    Tabata, Rie
    Fukuoka, Kazuya
    Nakano, Takashi
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (10) : 1721 - 1726
  • [10] PROGNOSTIC FACTORS AND SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA
    VANGELDER, T
    DAMHUIS, RAM
    HOOGSTEDEN, HC
    EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (06) : 1035 - 1038